NCT06822166 - Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

January 23, 2024

Study Completion Date

January 23, 2024

Conditions

Interaction Drug Food

Interventions

DRUG

rifampicin

rifampicin capsule，600 mg

DRUG

Fluconazole

Fluconazole capsules: 400 mg for the first dose and 200 mg for the remaining doses

DRUG

Omeprazole

Omeprazole enteric-coated capsules: 20 mg

DRUG

midazolam

midazolam injection 0.05 mg/kg was administered intravenously

DRUG

ET-26

the dose is 0.8 mg/kg, single dose, Infusion time was 60seconds ± 5seconds

Trial Locations (1)

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital of Shandong Province), Jinan